Skip to main content

Table 1 Baseline characteristics of the patients with ASCVD and at high risks for ASCVD

From: Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

Characteristics

2014

2015

Patients to estimate prevalence

Patients to estimate incidence

Patients to estimate prevalence

Patients to estimate incidence

Patients with ASCVD

 Number of patients

4,073,832

2,431,291

4,235,437

2,535,664

 Age at index (mean, SD)

63.77

13.40

62.04

14.20

64.07

13.43

62.31

14.20

 Male (n, %)

1,917,135

47.1%

1,115,023

45.9%

2,004,384

47.3%

1,171,480

46.2%

Patients with diabetes

4,742,145

  

Patients with diabetes without ASCVD

 Number of patients

    

4,189,371

1,368,326

 Age at index (mean, SD)

    

60.87

13.38

57.22

14.68

 Male (n, %)

    

2,158,643

51.5%

673,252

49.2%

Patients with hypertension

8,658,743

  

Patients with hypertension without ASCVD

 Number of patients

    

7,349,810

1,052,252

 Age at index (mean, SD)

    

62.50

12.97

56.16

14.34

 Male (n, %)

    

3,605,515

49.1%

581,354

55.3%

Patients with dyslipidemia

8,964,197

  

Patients with dyslipidemia without ASCVD

 Number of patients

    

7,809,475

3,265,877

 Age at index (mean, SD)

    

57.21

14.11

52.45

15.16

 Male (n, %)

    

3,561,808

45.6%

1,522,747

46.6%

  1. ASCVD atherosclerotic cardiovascular disease, CCI Charlson Comorbidity Index, SD standard deviation, HIV human immunodeficiency virus, AIDS acquired immunodeficiency syndrome